Clinical trial
Laser Ablation of Papillary Thyroid Microcarcinoma
Laser Ablation of Papillary Thyroid Microcarcinoma
The purpose of this study is to explore whether percutaneous laser ablation (PLA) is a safe and effective alternative to removing papillary thyroid microcarcinoma (PTMC) with surgery.
Study Type: Interventional (Clinical Trial)
Estimated Enrollment: 10 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Pilot Study to Evaluate the Safety and Efficacy of Percutaneous Laser Ablation of Thyroid Papillary Microcarcinoma
Actual Study Start Date: October 19, 2020
Estimated Primary Completion Date: October 2022
Estimated Study Completion Date: October 2022
Arm:
- Experimental: Participants with papillary microcarcinoma (PTMC)
| Category | Value |
|---|---|
| Study type(s) | Interventional |
| Estimated enrolment | 10 |
| Actual Study start date | 19 October 2020 |
| Estimated Study Completion Date | 01 October 2022 |